Strata Oncology is improving enrollment in precision oncology clinical trials by providing genetic sequencing for late-stage cancer patients.
strataoncology.com
Ann Arbor, MI
CEO: Dan Rhodes, PhD
Arboretum Lead: Jan Garfinkle
Strata Oncology
IN THE NEWS
Strata Oncology Announces Appointment of Goz Alhir as Senior Vice President of Commercialization
Strata Oncology, Inc., a next-generation precision oncology company enabling smarter cancer treatment, recently announced the appointment of Goz Alhir as Senior Vice President, Commercialization.
Read More
Strata Oncology Announces Launch and Medicare Coverage for Strata Select, a First-of-its-kind Immunotherapy Test
Strata Oncology, Inc. (“Strata”), a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced the launch of Strata SelectTM, a first-of-its-kind molecular profiling test for patients with advanced…
Read More
